🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Donor Site Morbidity and Buccinator Muscle Integrity After Buccinator Myomucosal Flap Surgery in Patients With Velopharyngeal Incompetence

Recruitingn/aAges 18 Years - anyAllSohag University
NCT07853872 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to evaluate donor site morbidity and buccinator muscle integrity following the use of buccinator myomucosa flap in patients with velopharyngeal incompetence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with velopharyngeal incompetence undergoing palatal lengthening using bilateral posteriorly based buccinator myomucosal flaps. * Non-syndromic patients. Exclusion Criteria: * Syndromic cleft patients with associated neuromuscular disorders. * History of previous cheek surgery affecting the buccinator muscle. * Patients who declined participation in the study.
💊

What it tests

  • Bilateral posteriorly based buccinator myomucosal flap surgery
📍

Where

1 site
Sohag University
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy